Ralf Kircheis

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 7

Top Topics

Inflammatory Response

Respiratory Syndrome Coronavirus

Signaling Pathway

Top Venues

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Ralf Kircheis
In Silico Analyses Indicate a Lower Potency for Dimerization of TLR4/MD-2 as the Reason for the Lower Pathogenicity of Omicron Compared to Wild-Type Virus and Earlier SARS-CoV-2 Variants. International journal of molecular sciences 25 (10) (2024)
Ralf Kircheis
In Silico Analyses Indicate a Lower Potency for Dimerization of TLR4/MD-2 as the Reason for the Lower Pathogenicity of Omicron Compared to Wild-Type Virus and Earlier SARS-CoV-2 Variants. International journal of molecular sciences 25 (10) (2024)
Ralf Kircheis
In Silico Analyses Indicate a Lower Potency for Dimerization of TLR4/MD-2 as the Reason for the Lower Pathogenicity of Omicron Compared to Wild-Type Virus and Earlier SARS-CoV-2 Variants. International journal of molecular sciences 25 (10) (2024)
Ralf Kircheis, Oliver Planz
The Role of Toll-like Receptors (TLRs) and Their Related Signaling Pathways in Viral Infection and Inflammation. International journal of molecular sciences 24 (7) (2023)
Ralf Kircheis, Oliver Planz
Could a Lower Toll-like Receptor (TLR) and NF-κB Activation Due to a Changed Charge Distribution in the Spike Protein Be the Reason for the Lower Pathogenicity of Omicron? International journal of molecular sciences 23 (11) (2022)
Ralf Kircheis
Coagulopathies after Vaccination against SARS-CoV-2 May Be Derived from a Combined Effect of SARS-CoV-2 Spike Protein and Adenovirus Vector-Triggered Signaling Pathways. International journal of molecular sciences 22 (19) (2021)
Ralf Kircheis, Manfred Schuster, Oliver Planz
COVID-19: Mechanistic Model of the African Paradox Supports the Central Role of the NF-κB Pathway. Viruses 13 (9) (2021)